✦ LIBER ✦

Ponatinib: hope for patients with CML or Ph-positive ALL?

✍ Scribed by Yaqub, Farhat

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PACE: A Pivotal Phase 2 Trial of Ponatin

✍ Cortes, Jorge E.; Kim, Dong-Wook; Pinilla, Javier; Paquette, Ronald; le Coutre, 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 65 KB

A Phase I/II study of nilotinib in Japan

✍ Arinobu Tojo; Kensuke Usuki; Akio Urabe; Yasuhiro Maeda; Yukio Kobayashi; Itsuro 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 184 KB

Therapeutic choices in patients with Ph-

✍ Ruiz-Argüelles, G J; Tarin-Arzaga, L C; Gonzalez-Carrillo, M L; Gutierrez-Rivero 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

Efficacy and safety of nilotinib in Japa

✍ Kensuke Usuki; Arinobu Tojo; Yasuhiro Maeda; Yukio Kobayashi; Akira Matsuda; Kaz 📂 Article 📅 2012 🏛 Carden Jennings Publishing 🌐 English ⚖ 285 KB

Imatinib Maintenance Following Allogenei

✍ P. Kebriaei; A. Chiattone; R. Saliba; D. Jones; P. Anderlini; B. Andersson; I. K 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Biclonal blast crisis with a mutated ABL

✍ Alimena, G; Breccia, M; Mancini, M; Diverio, D; Nanni, M; De Propris, M S; Cimin 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 68 KB